ImmunityBio, Inc.
$7.91
The Read: ImmunityBio's stock surged over 70% on the successful sBLA resubmission for ANKTIVA in Papillary NMIBC, then fell 25%.
IBRX
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$7.91
The Read: ImmunityBio's stock surged over 70% on the successful sBLA resubmission for ANKTIVA in Papillary NMIBC, then fell 25%.
No Data